{"slideshow_credits": null, "snippet": "The chief of Turing Pharmaceuticals, who increased a drug\u2019s price to $750 from $13.50 a pill, has been bashed as the face of corporate greed. But he\u2019s still smiling.", "abstract": "Turing Pharmaceuticals founder and chief executive Martin Shkreli has been vilified for raising price of decades-old drug overnight to $750 a pill from $13.50; he counters that revenue from reinvented drug will fund development of new drugs for debilitating diseases.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Julie", "role": "reported", "lastname": "CRESWELL", "rank": 1, "organization": ""}, {"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 2, "organization": ""}], "original": "By JULIE CRESWELL and ANDREW POLLACK", "contributor": "Rachel Abrams contributed reporting."}, "web_url": "http://www.nytimes.com/2015/12/06/business/martin-shkreli-the-bad-boy-of-pharmaceuticals-hits-back.html", "lead_paragraph": "The chief of Turing Pharmaceuticals, who increased a drug\u2019s price to $750 from $13.50 a pill, has been bashed as the face of corporate greed. But he\u2019s still smiling.", "headline": {"main": "Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back", "print_headline": "The Bad Boy of Pharmaceuticals Hits Back"}, "_id": "566313a838f0d87104c915eb", "word_count": "2470", "multimedia": [{"height": 126, "url": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 422, "url": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-articleLarge.jpg", "legacy": {"xlarge": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "422"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/12/06/business/06-SHKRELI/06-SHKRELI-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-06T00:00:00Z", "source": "The New York Times", "news_desk": "SundayBusiness", "keywords": [{"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Hunter College High School", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}